| 000 | 01261nam a2200361Ia 4500 | ||
|---|---|---|---|
| 001 | 008929 | ||
| 008 | 141222s9999 xx 000 0 und d | ||
| 040 | _aDB/INS | ||
| 041 | 0 | _aeng | |
| 210 | 1 | 0 | _aAm. J. Trop. Med. Hyg |
| 245 | 0 | 0 | _aTreatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study |
| 245 | 0 | 0 | _cJM Soto, JT Toledo, P Gutierrez … [et.al] |
| 260 | _aOhio | ||
| 260 | _bAmerican Society of Tropical Medicine and Hygiene | ||
| 260 | _c2002 | ||
| 300 | _a147-51 | ||
| 300 | _btbls.;ilus | ||
| 362 | 1 | _aVol. 66, no. 2 (feb. 2002) | |
| 520 | _aWe studied the efficacy of WR279396, a topical formulation of aminoglycosides that cures 100 per cent of cutaneous leishmaniasis lesions in mice. We conducted what is to our knowledge the first controlled study of WR279396 therapy for clinical cutaneous l | ||
| 650 | 1 | _aLeishmaniasis cutánea | |
| 650 | 2 | _aAdministración tópica | |
| 650 | 2 | _aBibliografía del INS4 | |
| 650 | 2 | _aTerapia combinada | |
| 700 | 1 | _aArboleda, M | |
| 700 | 1 | _aBerman, JD | |
| 700 | 1 | _aEnglish, CK | |
| 700 | 1 | _aGrogl, M | |
| 700 | 1 | _aGutierrez, P | |
| 700 | 1 | _aNicholls, RS | |
| 700 | 1 | _aPadilla, JR | |
| 700 | 1 | _aSoto, JM | |
| 700 | 1 | _aToledo, JT | |
| 999 |
_c18348 _d18348 |
||